Back to top

Image: Bigstock

NextGen Healthcare, Inc.

Read MoreHide Full Article

NextGen’s lowered guidance for fiscal 2019 indicates looming concerns ahead. The company’s plummeting gross profit is a negative. Sluggishness in the recurring revenue segment is a woe. The company faces stiff competition in MedTech space. On the brighter side, the company outperformed its industry in a year’s time. The company rides on Software, hardware and other non-recurring segment. Management currently foresees solid growth prospects in the RCM pipeline as well. The NextGen population health analytics suite and NextGen mobile platform registered significant growth. Solid bookings growth deserves mention. For investors’ notice, the company expects high-single digit revenue growth by fiscal 2020. NextGen announced the availability of Quality/Cost Fusion – a new Population Health analytics capability. Quality/Cost Fusion is a part of NextGen Population Health platform – a modular, cloud-based solution.

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: